Declines in vaccine-type human papillomavirus prevalence in females across racial/ethnic groups: data from a national survey

NM McClung, RM Lewis, JW Gargano, T Querec… - Journal of Adolescent …, 2019 - Elsevier
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …

Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey

NM McClung, RM Lewis… - The Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14-34 years in the …

Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.

NM McClung, RM Lewis, JW Gargano… - The Journal of …, 2019 - europepmc.org
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14-34 years in the …

Declines in vaccine-type human papillomavirus prevalence in females across racial/ethnic groups: data from a national survey.

NM McClung, RM Lewis, JW Gargano, T Querec… - 2019 - cabidigitallibrary.org
Purpose: To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14-34 years in the …

Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey

NM McClung, RM Lewis, JW Gargano… - Journal of Adolescent …, 2019 - jahonline.org
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …